Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer

Yohei Funakoshi; Kimikazu Yakushijin; Goh Ohji; Wataru Hojo; Hironori Sakai; Ryo Takai; Taku Nose; Shinya Ohata; Yoshiaki Nagatani; Taiji Koyama; Akihito Kitao; Meiko Nishimura; Yoshinori Imamura; Naomi Kiyota; Kenichi Harada; Yugo Tanaka; Yasuko Mori; Hironobu Minami

doi:10.1101/2021.10.25.21265324

Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer

View ORCID ProfileYohei Funakoshi, View ORCID ProfileKimikazu Yakushijin, View ORCID ProfileGoh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, Taku Nose, Shinya Ohata, Yoshiaki Nagatani, Taiji Koyama, Akihito Kitao, Meiko Nishimura, Yoshinori Imamura, View ORCID ProfileNaomi Kiyota, Kenichi Harada, Yugo Tanaka, Yasuko Mori, View ORCID ProfileHironobu Minami

doi: https://doi.org/10.1101/2021.10.25.21265324

Yohei Funakoshi

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yohei Funakoshi
For correspondence: yohei{at}med.kobe-u.ac.jp

Kimikazu Yakushijin

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kimikazu Yakushijin

Goh Ohji

2Division of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Goh Ohji

Wataru Hojo

3R&D, Cellspect Co., Ltd., Morioka, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hironori Sakai

3R&D, Cellspect Co., Ltd., Morioka, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ryo Takai

4Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Taku Nose

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shinya Ohata

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yoshiaki Nagatani

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Taiji Koyama

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Akihito Kitao

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Meiko Nishimura

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yoshinori Imamura

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Naomi Kiyota

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

5Cancer Center, Kobe University Hospital, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Naomi Kiyota

Kenichi Harada

6Division of Urology, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yugo Tanaka

7Division of Thoracic Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yasuko Mori

8Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hironobu Minami

1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan

5Cancer Center, Kobe University Hospital, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hironobu Minami

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

View the discussion thread.

PreviousNext

Posted October 25, 2021.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer

Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, Taku Nose, Shinya Ohata, Yoshiaki Nagatani, Taiji Koyama, Akihito Kitao, Meiko Nishimura, Yoshinori Imamura, Naomi Kiyota, Kenichi Harada, Yugo Tanaka, Yasuko Mori, Hironobu Minami

medRxiv 2021.10.25.21265324; doi: https://doi.org/10.1101/2021.10.25.21265324

Share This Article: